The Atypical Presentation of Ifosfamide-Induced Renal Tubular Acidosis

Area of Science:

• Nephrology
• Oncology
• Pharmacology

Background:

• Ifosfamide is a cytotoxic chemotherapy agent used for metastatic osteosarcoma.
• It is known to cause renal tubular injury, often presenting as metabolic acidosis (Type 1 or Type 2 Renal Tubular Acidosis).
• Diagnosis and management of ifosfamide-induced RTA are well-established.

Observation:

• A patient undergoing ifosfamide treatment for osteosarcoma developed acute, symptomatic hypokalemia.
• This patient did not exhibit the typical laboratory findings associated with ifosfamide-induced renal tubular acidosis.
• The presentation deviated from the commonly observed pattern of renal dysfunction.

Findings:

• The case suggests a potential diagnosis of Type 3 Renal Tubular Acidosis.
• This implies involvement of both proximal and distal tubular segments.
• The findings challenge the established understanding of ifosfamide's renal toxicity profile.

Implications:

• This case expands the spectrum of renal tubular acidosis presentations associated with ifosfamide.
• It underscores the importance of considering atypical presentations in patients receiving this chemotherapy.
• Further investigation into mixed RTA types may be warranted for optimizing patient care and monitoring.